Related Experiment Video

Updated: May 5, 2026

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

16.6K

Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease

Linda L Humphrey1, Benjamin K S Chan, Harold C Sox

  • 1Veterans Affairs Medical Center and Oregon Health & Science University, Portland, Oregon 97201, USA.

Annals of Internal Medicine
|August 21, 2002
PubMed

Insights

Hormone replacement therapy (HRT) does not appear to prevent cardiovascular disease (CVD) or coronary artery disease (CAD). Further research using randomized controlled trials is needed to confirm the role of HRT in primary CVD prevention.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Preventive Medicine

Background:

  • Hormone replacement therapy (HRT) has been investigated for its potential role in preventing cardiovascular disease (CVD).
  • Previous studies have yielded conflicting results regarding the efficacy of HRT in primary prevention of CVD and coronary artery disease (CAD).

Purpose of the Study:

  • To evaluate the effectiveness of hormone replacement therapy (HRT) in the primary prevention of cardiovascular disease (CVD) and coronary artery disease (CAD).

Main Methods:

  • A comprehensive literature search of MEDLINE and Cochrane databases was conducted for primary prevention studies on HRT, CVD, and CAD.
  • Studies were reviewed, abstracted, and quality-rated using U.S. Preventive Services Task Force (USPSTF) criteria.
  • Meta-analysis was performed on good or fair quality studies, with further analysis adjusting for potential confounding factors.

Main Results:

  • The summary relative risk for CVD mortality with HRT was 0.75 (95% CrI, 0.42-1.23) and for CAD mortality was 0.74 (95% CrI, 0.36-1.45).
  • Summary relative risk for CVD incidence was 1.28 (95% CrI, 0.86-2.00) and for CAD incidence was 0.87 (95% CrI, 0.62-1.21).
  • Adjusted analyses indicated no significant benefit of HRT for CAD incidence, suggesting confounding by socioeconomic status, alcohol consumption, and exercise.

Conclusions:

  • This meta-analysis suggests that HRT does not provide a benefit in the primary prevention of CVD or CAD.
  • Findings align with recent randomized trials indicating no protective effect of HRT on CVD events.
  • Randomized, controlled trials are essential to definitively determine the role of HRT in primary CVD prevention.
Abstract

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

11.7K
Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

1.2K

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655